- 1Department of Interventional Radiology and Vascular Surgery, The First Affiliated Hospital of Hainan Medical University, Hainan Medical University, Haikou, China
- 2Department of Emergency, The First Affiliated Hospital of Hainan Medical University, Hainan Medical University, Haikou, China
- 3Key Laboratory of Emergency and Trauma of Hainan Medical University, Ministry of Education, Key Laboratory of Hainan Trauma and Disaster Rescue, Hainan Medical University, Haikou, China
- 4Division of Vascular Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
- 5Hainan Medical University, Haikou, China
A Correction on
Application of modified sodium alginate hydrogel for interventional embolization of hemorrhagic diseases
by Wei S, Deng T, Wu C, Shi J, Liao Y, Huang L, Liu Y, Zhong S, Ji X and Jin G (2024). Front. Mater. 10:1329667. doi: 10.3389/fmats.2023.1329667
In the published article, there was an error in Figure 6. The updated Figure appears below.
Figure 6. Evaluation of IIA hemorrhage after embolization with different embolic materials (a) ELISA for plasma Il-1β, (b) ELISA for plasma TGF-α, (c) ELISA for homogenate Il-1β, (d) ELISA for homogenate TGF-α; and (e) histopathology analyes.
The original article has been updated.
Generative AI statement
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: modified sodium alginate hydrogel, embolic agent, animal model of hemorrhage, interventional embolization, biomaterial
Citation: Wei S, Deng T, Wu C, Shi J, Liao Y, Huang L, Liu Y, Zhong S, Ji X and Jin G (2026) Correction: Application of modified sodium alginate hydrogel for interventional embolization of hemorrhagic diseases. Front. Mater. 12:1756535. doi: 10.3389/fmats.2025.1756535
Received: 28 November 2025; Accepted: 18 December 2025;
Published: 07 January 2026.
Edited and reviewed by:
Liqun Yang, Shengjing Hospital of China Medical University, ChinaCopyright © 2026 Wei, Deng, Wu, Shi, Liao, Huang, Liu, Zhong, Ji and Jin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Guiyun Jin, MTM5NzY2MDk2MjVAMTYzLmNvbQ==; Xueying Ji, aml4dWV5aW5nQDE2My5jb20=
†These authors have contributed equally to this work
Shengchao Wei1,2,3†